Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-Release Naltrexone for Methamphetamine Dependence in MSM
NCT01449565Phase 2Completed
- Sponsor
- San Francisco Department of Public Health
- Start
- Sep 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in methamphetamine use disorder (MUD), sponsored by San Francisco Department of Public Health. Started Sep 2012; status: completed.
02
Drugs
naltrexone
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT01449565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449565.